{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:51:05Z","timestamp":1787028665505,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is increasingly recognized as a risk factor for cognitive decline and dementia, independent of clinically apparent stroke. This narrative review synthesizes current evidence on pathophysiological mechanisms linking AF to cognitive decline, including cerebral hypoperfusion, silent cerebral infarction, microembolism, systemic inflammation, and shared vascular risk factors. A structured literature search was conducted in PubMed and ScienceDirect from January 2000 to October 2025, with evidence quality assessed using adapted Newcastle\u2013Ottawa Scale criteria. Observational evidence suggests that oral anticoagulation, particularly with direct oral anticoagulants (DOACs), may be associated with reduced dementia risk compared to no treatment or vitamin K antagonists. However, most intervention studies were not designed with cognitive endpoints as primary outcomes, limiting causal inference. Current evidence supports comprehensive AF management, including guideline-directed anticoagulation, appropriate rhythm or rate control, and aggressive modification of shared risk factors. Atrial fibrillation is consistently associated with increased risk of cognitive decline and dementia through multiple interrelated mechanisms; however, randomized trials with cognitive endpoints are needed to establish causality.<\/jats:p>","DOI":"10.3390\/jcm15051899","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:24:34Z","timestamp":1772447074000},"page":"1899","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atrial Fibrillation and Cognitive Decline: Mechanisms, Evidence, and Preventive Strategies\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Dania","family":"Hasanein","sequence":"first","affiliation":[{"name":"Department of Advanced Cardiology and Hemostaseology Research, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5725-8753","authenticated-orcid":false,"given":"Daniel Florin","family":"Lighezan","sequence":"additional","affiliation":[{"name":"Department of Advanced Cardiology and Hemostaseology Research, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana Elena","family":"\u021aunea","sequence":"additional","affiliation":[{"name":"Department of Advanced Cardiology and Hemostaseology Research, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Gabriela","family":"Ciobotaru","sequence":"additional","affiliation":[{"name":"Department of Medical Semiology I, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norina Simona","family":"Ba\u0219a","sequence":"additional","affiliation":[{"name":"Department of Medical Semiology I, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/europace\/euac003","article-title":"Predictive Role of Atrial Fibrillation in Cognitive Decline: A Systematic Review and Meta-Analysis of 2.8 Million Individuals","volume":"24","author":"Koh","year":"2022","journal-title":"Europace"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jacc.2018.10.077","article-title":"Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week","volume":"73","author":"Diener","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the Management of Atrial Fibrillation","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2009.12.004","article-title":"Atrial Fibrillation Is Independently Associated with Dementia","volume":"7","author":"Bunch","year":"2010","journal-title":"Heart Rhythm"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chaudhari, M., Bhatti, G.K., and Goldwater, D.S. (2025). Neuropsychiatry of Atrial Fibrillation: Dementia and Beyond. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1485837"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/B978-0-12-819814-8.00023-8","article-title":"The Relationship Between Heart Disease and Cognitive Impairment","volume":"Volume 177","author":"Miller","year":"2021","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jamda.2024.01.010","article-title":"Atrial Fibrillation and Dementia: Focus on Shared Pathophysiological Mechanisms","volume":"25","author":"Carbone","year":"2024","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15420\/AER.2015.04.02.100","article-title":"Anticoagulation in Atrial Fibrillation\u2014Current Concepts","volume":"4","author":"Katritsis","year":"2015","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of Thrombogenesis in Atrial Fibrillation: Virchow\u2019s Triad Revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-158-5-201303050-00007","article-title":"Cognitive Impairment Associated with Atrial Fibrillation: A Meta-Analysis","volume":"158","author":"Kalantarian","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jce.12608","article-title":"Silent Cerebral Events\/Lesions Related to Atrial Fibrillation Ablation","volume":"26","author":"Deneke","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.36922\/bh.4702","article-title":"Atrial Fibrillation and Risk of Cognitive Impairment and Dementia: Relationships, Potential Mechanisms, and Current Therapies","volume":"3","author":"Guo","year":"2025","journal-title":"Brain Heart"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/europace\/eux220","article-title":"Atrial Fibrillation Is Associated with Decreased Total Cerebral Blood Flow","volume":"20","author":"Gardarsdottir","year":"2018","journal-title":"Europace"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15420\/ecr.2016:13:2","article-title":"Atrial Fibrillation, Cognitive Decline and Dementia","volume":"11","author":"Alonso","year":"2016","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28635","DOI":"10.1038\/srep28635","article-title":"Transient Cerebral Hypoperfusion During Atrial Fibrillation","volume":"6","author":"Anselmino","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_17","first-page":"2272","article-title":"Impaired Cerebrovascular Reactivity in Patients with Atrial Fibrillation","volume":"75","author":"Junejo","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/jcbfm.1989.62","article-title":"Cerebral Blood Flow Before and After Cardioversion of Atrial Fibrillation","volume":"9","author":"Petersen","year":"1989","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the Pathogenesis of Atrial Fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/joa3.12077","article-title":"Inflammation and Atrial Fibrillation: A Comprehensive Review","volume":"34","author":"Korantzopoulos","year":"2018","journal-title":"J. Arrhythm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2990.2012.01307.x","article-title":"Review: Systemic Inflammation and Alzheimer\u2019s Disease","volume":"39","author":"Holmes","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.niox.2023.03.003","article-title":"Dual Role of Nitric Oxide in Alzheimer\u2019s Disease","volume":"134\u2013135","author":"Azargoonjahromi","year":"2023","journal-title":"Nitric Oxide"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Karakasis, P., Theofilis, P., Milaras, N., Vlachakis, P.K., Patoulias, D., Karamitsos, T., Antoniadis, A.P., and Fragakis, N. (2025). Epigenetic Drivers of Atrial Fibrillation: Mechanisms, Biomarkers, and Therapeutic Targets. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115253"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, Incidence and Lifetime Risk of Atrial Fibrillation","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur. Heart J."},{"key":"ref_25","first-page":"e80415","article-title":"Diabetes Mellitus and Cognitive Decline: A Systematic Review Exploring the Link to Dementia and Neurodegenerative Diseases","volume":"17","author":"Khaliq","year":"2025","journal-title":"Cureus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejim.2023.10.033","article-title":"Direct Oral Anticoagulants Are Associated with Lower Risk of Dementia","volume":"121","author":"Sagris","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.119.14388","article-title":"Blood Pressure Control and Dementia Risk in AF Patients","volume":"75","author":"Kim","year":"2020","journal-title":"Hypertension"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1540-8167.2011.02035.x","article-title":"Patients Treated with Catheter Ablation for Atrial Fibrillation Have Lower Dementia Risk","volume":"22","author":"Bunch","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.123.066477","article-title":"Arterial Thromboembolism in Patients with Atrial Fibrillation and CHA2DS2-VASc Score 1: A Nationwide Study","volume":"149","author":"Olesen","year":"2024","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kumar, V., and Ilkhanoff, L. (2024). Anticoagulants for Atrial Fibrillation: From Warfarin and DOACs to Factor XI Inhibitors. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1352734"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS Guideline for AF Management","volume":"74","author":"January","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.36922\/an.3799","article-title":"Oral Anticoagulants as Potential Neuroprotective Therapeutics","volume":"3","author":"Grossmann","year":"2024","journal-title":"Adv. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control Therapy in Patients with AF","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/07853890.2021.1930137","article-title":"Rate Control Strategies for Atrial Fibrillation","volume":"53","author":"Alobaida","year":"2021","journal-title":"Ann. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients with Atrial Fibrillation (CABANA)","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100386","DOI":"10.1016\/j.cpcardiol.2018.07.001","article-title":"Atrial Fibrillation and Deterioration in Cognitive Function","volume":"44","author":"Chinta","year":"2019","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_37","first-page":"849","article-title":"Association of Atrial Fibrillation with Cognitive Decline and Dementia","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4244\/EIJY14M09_18","article-title":"EHRA\/EAPCI Expert Consensus on LAA Occlusion","volume":"10","author":"Meier","year":"2015","journal-title":"EuroIntervention"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous LAA Closure versus Warfarin for Stroke Prevention","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study","volume":"64","author":"Pathak","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-Term Effect of Goal-Directed Weight Management in An Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1899\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:54:52Z","timestamp":1772448892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/5\/1899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["jcm15051899"],"URL":"https:\/\/doi.org\/10.3390\/jcm15051899","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}